java zxing read barcode from image TOXIC MYOPATHIES in Objective-C

Drawing Data Matrix 2d barcode in Objective-C TOXIC MYOPATHIES

TOXIC MYOPATHIES
Recognize ECC200 In Objective-C
Using Barcode Control SDK for iPhone Control to generate, create, read, scan barcode image in iPhone applications.
Making DataMatrix In Objective-C
Using Barcode maker for iPhone Control to generate, create Data Matrix image in iPhone applications.
11 12
Decode Data Matrix In Objective-C
Using Barcode decoder for iPhone Control to read, scan read, scan image in iPhone applications.
Barcode Creation In Objective-C
Using Barcode generator for iPhone Control to generate, create bar code image in iPhone applications.
14 15
DataMatrix Drawer In Visual C#.NET
Using Barcode creation for .NET framework Control to generate, create Data Matrix 2d barcode image in Visual Studio .NET applications.
Create DataMatrix In .NET Framework
Using Barcode drawer for ASP.NET Control to generate, create Data Matrix image in ASP.NET applications.
17 18
Data Matrix Creator In .NET
Using Barcode creator for .NET Control to generate, create Data Matrix image in .NET applications.
Make Data Matrix In Visual Basic .NET
Using Barcode generation for VS .NET Control to generate, create Data Matrix image in .NET applications.
19 20
Making Code 128 In Objective-C
Using Barcode creator for iPhone Control to generate, create Code 128 Code Set C image in iPhone applications.
Making EAN-13 In Objective-C
Using Barcode generator for iPhone Control to generate, create UPC - 13 image in iPhone applications.
21 22 23
Bar Code Maker In Objective-C
Using Barcode printer for iPhone Control to generate, create barcode image in iPhone applications.
Paint DataMatrix In Objective-C
Using Barcode generation for iPhone Control to generate, create DataMatrix image in iPhone applications.
24 25 26
EAN / UCC - 8 Drawer In Objective-C
Using Barcode maker for iPhone Control to generate, create EAN-8 Supplement 5 Add-On image in iPhone applications.
Generate Barcode In None
Using Barcode generation for Microsoft Word Control to generate, create barcode image in Word applications.
31 Reaven P, Witzum J Lovastatin, nicotinic acid and rhabdomyolysis [letter] Ann Intern Med 1988;109:597 598 32 Fux R, Morike K, Gundel UF, Hartmann R, Gleiter CH Ezetimibe and statin-associated myopathy Ann Intern Med 2004;140(8):671 672 33 Havranek JM, Wolfsen AR, Warnke GA, Phillips PS Monotherapy with ezetimibe causing myopathy Am J Med 2006;119(3):285 286 34 Simard C, Poirier P Ezetimibe-associated myopathy in monotherapy and in combination with a 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitor Can J Cardiol 2006;22(2):141 144 35 Perez-Calvo J, Civeira-Murillo F, Cabello A Worsening myopathy associated with ezetimibe in a patient with McArdle disease QJM 2005;98(6):461 462 36 Dujovne CA, Chremos AN, Pool JL, et al Expanded Clinical Evaluation of Lovastatin (EXCEL) study results IV Additional perspectives on the tolerability of lovastatin Am J Med 1991;(Suppl 1B):25 30 37 Jones P, Kafonek S, Laurora I, Hunningshake D, the CURVES Investigators Comparative dose ef cacy study of atorvastatin versus simvastatin, provastatin, lovastatin, and uvastatin in patients with hypercholesterolemia (the CURVES Study) Am J Cardiol 1998;81:582 587 38 Galper JB Increase incidence of myositis in patients treated with high dose simvastatin Am J Cardiol 1998; 81:259 39 Duell PB, Connor WE, Illingsworth DR Rhabdomyolysis after taking atorvastatin with gem brozil Am J Cardiol 1998;81:368 369 40 Furberg CD, Pitt B Commentary: Withdrawal of cervistatin from the world market Curr Control Trials Cardiovasc Med 2001;2:205 207 41 von Keutz E, Schluter G Preclinical safety evaluation of cerivastation, a novel HMG-CoA reductase inhibitor Am J Cardiol 1998;82(4B):11J 17J 42 Hamilton-Craig I Statin-associated myopathy Med J Aust 2001;175:486 489 43 Pasternak RC, Smith SC, Bairey-Merz CN, Grundy S, Cleeman J, Lenfant C ACC/AHA/NHLBI clinical advisory on the use and safety of statins J Am Coll Cardiol 2002;40:56 572 44 Icor 2000 45 Hodel C Myopathy and rhabdomyolysis with lipidlowering drugs Toxicol Lett 2002;128:159 168 46 Thompson PD, Clarkson P, Karas RH Statin-associated myopathy JAMA 2003;289:1681 1690 47 Ayanian JZ, Fuch CS, Stone RM Lovastatin and rhabdomyolysis Ann Intern Med 1988;109:682 683 48 Fauchais AL, Iba Ba J, Maurage P, et al Polymyositis induced or associated with lipid-lowering drugs: Five cases Rev Med Interne 2004;25(4):294 298 49 Giordano N, Senesi M, Mattii G, Battisti E, Villanova M, Gennari C Polymyositis associated with simvastatin Lancet 1997;349(9065):1600 1601 50 Hill C, Zeitz C, Kirkham B Dermatomyositis with lung involvement in a patient treated with simvastatin Aust N Z J Med 1995;25(6):745 746 51 Khattak FH, Morris IM, Branford WA Simvastatinassociated dermatomyositis Br J Rheumatol 1994;33(2): 199
Bar Code Encoder In .NET Framework
Using Barcode encoder for Visual Studio .NET Control to generate, create barcode image in .NET applications.
Matrix 2D Barcode Drawer In Java
Using Barcode printer for Java Control to generate, create Matrix Barcode image in Java applications.
SECTION II
Bar Code Drawer In None
Using Barcode encoder for Microsoft Excel Control to generate, create bar code image in Microsoft Excel applications.
Making USS-128 In Java
Using Barcode encoder for Java Control to generate, create GTIN - 128 image in Java applications.
SPECIFIC DISORDERS 74 Hanna JP, Ramundo ML Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children Neurology 1988;50:301 303 75 Parke TJ, Steven JE, Rice ASC, et al Metabolic acidosis and myocardial failure after propofol infusion in children: Five case reports Br Med J 1992;305:613 616 76 Strickland RA, Murray MJ Fatal metabolic acidosis in pediatric patient receiving and infusion of propofol in the intensive care unit: Is there a relationship Crit Care Med 1995;23:405 409 77 Hanson P, Dive A, Brucher J-M, Bisteau M, Dangoisse M, Deltombe T Acute corticosteroid myopathy in intensive care patients Muscle Nerve 1997;20:1371 1380 78 Eadie MJ, Ferrier TM Chloroquine myopathy J Neurol Neurosurg Psychiatry 1966;29:331 337 79 Estes ML, Ewing-Wilson D, Chou SM, et al Chloroquine neuromyotoxicity Clinical and pathological perspective Am J Med 1987;82:447 455 80 Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART) J Neurol Sci 2000;69:376 380 81 Mastaglia FL, Papadimitriou JM, Dawkins RL, et al Vacuolar myopathy associated with chloroquine, lupus erythematosus and thymoma J Neurol Sci 1977;34:315 328 82 Alderson K, Grif n JW, Cornblath DR, Levine JH, Kuncl RW, Grif n LSC Neuromuscular complications of amiodarone therapy Neurology 1987;37(Suppl):355 83 Costa-Jussa FR, Jacobs JM The pathology of amiodarone neurotoxicity I Experimental changes with reference to changes in other tissues Brain 1985;108:735 752 84 Jacobs JM, Costa-Jussa FR The pathology of amiodarone neurotoxicity II Peripheral neuropathy in man Brain 1985;108:753 769 85 Meier C, Kauer B, Muller U, Ludin HP Neuromyopathy during amiodarone treatment: A case report J Neurol 1979;220:231 239 86 Roth R, Itabashi H, Louie J, et al Amiodarone toxicity: Myopathy and neuropathy Am Heart J 1990;119:1223 1225 87 Kuncl RW, Duncan G, Watson D, et al Colchicine myopathy and neuropathy N Engl J Med 1987;316:1562 1568 88 Kuncl RW, Cornblath DR, Avila O, et al Electrodiagnosis of human colchicine myoneuropathy Muscle Nerve 1989;12:360 364 89 Riggs JE, Schochet SS, Gutmann L, et al Chronic colchicine neuropathy and myopathy Arch Neurol 1986; 43:521 523 90 Rutkove SB, De Girolami U, Preston DC, et al Myotonia in colchicine myoneuropathy Muscle Nerve 1996;19:870 875 91 Kontos HA Myopathy associated with chronic colchicine toxicity N Engl J Med 1962;266:38 39 92 Bradley WG, Lassman LP, Pearce GW, et al The neuromyopathy of Vincristine in Man: Clinical, electrophysiological and pathological studies J Neurol Sci 1970;10:107 131 93 Anderson P, Song S, Slotwiner P The ne structure of spheromembranous degeneration of skeletal muscle induced by vincristine J Neuropathol Exp Neurol 1967;26:15 24
Bar Code Generation In Java
Using Barcode generation for Java Control to generate, create bar code image in Java applications.
Scan Barcode In Visual Studio .NET
Using Barcode recognizer for .NET Control to read, scan read, scan image in .NET framework applications.
52 Noel B, Cerottini JP, Panizzon RG Atorvastatininduced dermatomyositis Am J Med 2001;110(8):670 671 53 Riesco-Eizaguirre G, Arpa-Gutierrez FJ, Gutierrez M, Toribio E Severe polymyositis with simvastatin use Rev Neurol 2003;37(10):934 936 54 Rodriguez-Garcia JL, Serrano Commino M Lovastatinassociated dermatomyositis Postgrad Med J 1996; 72(853):694 55 Vasconcelos OM, Campbell WW Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake Muscle Nerve 2004;30(6):803 807 56 Meriggioli MN, Barboi A, Rowin J, Cochran EJ HMGCoA reductase inhibitor myopathy: Clinical, electrophysiologic, and pathologic data in ve patients J Clin Neuromuscul Dis 2001;2:129 134 57 Phillips PS, Haas RH, Bannykh S, et al Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 2002;137:581 585 58 Greenberg SA, Amato AA Statin myopathies In Amato AA (ed) Continuum: Muscle Diseases, Vol 12 2006, pp 169 184 59 Kra SJ Muscle syndrome with clo brate usage Conn Med 1974;38:348 349 60 A AK, Hajj SS, Tekian A, et al Clo brate-induced myotoxicity in rats Eur Neurol 1984;23:182 197 61 Amato AA, Barohn RJ Neurological complications of transplantations In Harati Y, Rolack LA (eds) Practical Neuroimmunology Boston: Butterworth-Heineman, 1997, pp 341 375 62 Arellano F, Krup P Muscular disorders associated with cyclosporine [letter] Lancet 1991;337:915 63 Costigan DA Acquired myotonia, weakness and vacuolar myopathy secondary to cyclosporine [abstract] Muscle Nerve 1989;12:761 64 Goy JJ, Stauffer JC, Deruaz JP, et al Myopathy as a possible side effect cyclosporine Lancet 1989;1:1446 1449 65 Grezard O, Lebranchu Y, Birmele B, et al Cyclosporineinduced muscular toxicity Lancet 1990;1:177 66 Noppen D, Verlkeriers B, Dierckx R, et al Cyclosporine and myopathy Ann Intern Med 1987;107:945 946 67 Hibi S, Hisawa A, Tamai M, et al Severe rhabdomyolysis with tacrolimus [letter] Lancet 1995;346:702 68 Norman D, Illingworth DR, Munson J, Hosenpud J Myolysis and acute renal failure in heart transplant recipient receiving lovastatin N Engl J Med 1988;318:46 47 69 Rieger EH, Halasz NA, Wahlstrom HE Colchicine neuromyopathy after renal transplantation Transplantation 1990;49;1196 1198 70 Volin L, Jarventie, Ruut U Fatal rhabdomyolysis as a complication of bone marrow transplantation Bone Marrow Transplant 1990;6:59 60 71 Atkinson P, Joubert G, Barron A, et al Hypertrophic cardiomyopathy with tacrolimus in paediatric transplant patient Lancet 1995;345:894 896 72 Teicher A, Rosenthal T, Kissen E, Sarova I Labetololinduced toxic myopathy Br Med J 1981;282:1824 1825 73 Willis JK, Tilton AH, Harkin JC, Boineau FG Reversible myopathy due to labetolol Pediatr Neurol 1990;6:275 276
CHAPTER 32 94 Slotwiner P, Song S, Andersone P Spheromembranous degeneration of muscle induced by vincristine Arch Neurol 1966;15:172 176 95 Dalakas M HIV or zidovudine myopathy [letter] Neurology 1994;44:360 361 96 Dalakas MC, Illa I, Pezeshkpour GH, et al Mitochondrial myopathy caused by long-term zidovudine therapy N Engl J Med 1990;322:1098 1105 97 Gherardi R, Chariot P HIV or zidovudine myopathy [letter] Neurology 1994;44:361 362 98 Grau JM, Casademont J HIV or zidovudine myopathy [letter] Neurology 1994;44:361 99 Grau JM, Masanes F, Pedreo E, Casdemont J, FernandezSola J, Urbano-Marquez A Human immunode ciency virus type 1 infection and myopathy: Clinical relevance of zidovidine therapy Ann Neurol 1993;34:206 211 100 Mhiri C, Baudrimont M, Bonne G, et al Zidovudine myopathy: A distinctive disorder associated with mitochondrial dysfunction Ann Neurol 1991;29:606 614 101 Peters BS, Winer J, Landon DN, Stoffer A, Pinching AJ Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS Q J Med 1993;86:5 15 102 Richman DD, Fischl MA, Grieco HM, et al The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex N Engl J Med 1987;317: 192 197 103 Simpson DM, Bender AN Human immunode ciency virus-associated myopathy: Analysis of 11 patients Ann Neurol 1988;24:79 84 104 Simpson DM, Bender AN, Farraye J, Mendelson SG, Wolfe DE Human immunode ciency virus wasting syndrome represents a treatable myopathy Neurology 1990;40:535 538 105 Simpson DM, Slasor P, Dafni U, Berger J, Fischl MA, Hall C Analysis of myopathy in a placebo-controlled zidovudine trial Muscle Nerve 1997;20:382 385 106 Bailey RO, Turok DI, Jaufmann BP, et al Myositis and acquired immunode ciency syndrome Hum Pathol 1987;18:749 751 107 Bessen LJ, Green JB, Louie E, Seitzman P, Weinberg H Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC N Engl J Med 1988;2: 318:708 108 Chalmers AC, Greco CM, Miller RG Prognosis in AZT myopathy Neurology 1991;41:1181 1184 109 Manji H, Harrison MJG, Round JM, et al Muscle disease, HIV and zidovudine: The spectrum of muscle disease in HIV-infected individuals treated with zidovudine J Neurol 1993;240:479 488 110 Reyes MG, Casanova J, Varricchio F, et al Zidovudine myopathy Neurology 1992;42:1252 111 Simpson DM, Citak KA, Godfrey E, Godbold J, Wolfe D Myopathies associated with human immunode ciency virus and zidovudine: Can their effects be distinguished Neurology 1993;43:971 976 112 Simpson DA, Katzenstein DA, Hughes MD, et al Neuromuscular function in HIV infection: Analysis of a placebo-controlled combination antiviral trial AIDS Clinical Group 175/801 Study Team AIDS 1998;12:2425 2432
Copyright © OnBarcode.com . All rights reserved.